France has adopted a new law reinforcing the safety of health products.

This law was adopted in large part in an effort to restore public trust in the French pharmaceutical and medical device regulatory system, a confidence which has been shaken by such events as the Mediator® scandal.

The new law creates a new pharmaceutical regulatory body, Agence Nationale de Sécurité du Médicament et des Produits de Santé; aims to improve transparency around conflicts of interest; and reinforces pharmacovigilance.

Click here to read more.